Related Issuers
by Stephen Carter
Jun 25, 2025 8:45 AM ET
Dolcetto Holdco SpA (DOC Pharma) (DOLCTH) EUR990m 144A/Reg S sr sec notes 2-part. B3/B (stable/stable). Via BNP (B&D)/Barc jt glocos/DB jt physical books/IMI/Mizuho/CA/KKR jt books. No reg rights. List Lux. NY law. Settles 07/14.
- EUR TBD (EUR350m minimum) sr sec fixed-rate notes due 2032 (7y). NC3 (MWC B+50bp) (50%,25%,par). Equity claw: 2y 40%. IPO claw: 4y 50% at 101. Special call: 10% per year the first 3 years at 103. CoC at 101. 30/360. Denoms: 100x1. IPT: high 5s-6%. Price talk: 5.75% area (+/- 12.5bp).
- EUR TBD (EUR350m minimum) sr sec FRN due 2032 (7y). NC1 (MWC B+50bp) (par). CoC at 101. Actual/360. Denoms: 100x1. IPT: 3mE+400bp area at par. Price talk: E+375-400bp at par.
Roadshow (1-on-1s) 06/23-25 (investor call at 1pm UKT 06/30). Books close at 3pm UKT 06/25. Pricing 06/25 UK afternoon. UOP: repay $973m unitranche facility, GCP. Equity sponsors: TPG (804%), ICG (17.9%). Biz: leading Italian generic pharmaceutical company.
Deal roadshow: https://dealroadshow.com/ Entry code: DOC25.